Pfizer Pays $14.5M To End Whistleblowers’ FCA Suit

Law360, New York (October 20, 2011, 7:08 PM EDT) -- Pfizer Inc. agreed to pay $14.5 million to resolve claims brought by two ex-employee whistleblowers that it used kickbacks and deceptive marketing to convince Medicaid providers to prescribe a bladder control drug for off-label purposes, plaintiffs' attorneys said Thursday.

Former Pfizer sales representatives David Wetherhold and Marci Drimer brought the False Claims Act suit in Massachusetts federal court on behalf of the U.S. government, 49 states and the District of Columbia in 2006. They alleged Pfizer promoted Detrol as a treatment for prostate enlargement, a condition...
To view the full article, register now.